Valeant Finally Files Report For March-ending Quarter

Valeant Pharmaceutical International Inc. filed a long-overdue quarterly report late Tuesday a few days after receiving a default notice. Valeant shares ticked up 0.2% to $24.70 after hours. On Thursday, Valeant said it had received a default notice under two of its senior note indentures because of the late filing. The company filed its late annual report in April. Shares dropped nearly 15% during Tuesday's regular session after the drug maker slashed its outlook for the year.